For all those dooms dayers , three patients dropped out for personal reasons , we are talking about Thailand , many of us have personal reasons not to do things , I would suggest that these people now regret their decision as 88 percent of their peers have now been cured . Cardio related drop outs , in any trial the trial managers must act on the side of caution and did , no one can afford to kill patients in trials , the side of caution will always be taken , as pointed out by the Cardio specialists in the states suggesting the withdrawal of these patients was unnecessary .
ii trader , this trial was not managed by Biotron , it was a third party that actually managed the trial and its results , and was done in Thailand for financial constraints . You will find the next trial will be done in USA , whilst the dosage may have been a little excessive , this is why we do several trials to obtain medical data to get it right and righter .
The trial has been deemed safe and we will continue to work toward a partner and also commercialization .
J8 , you could easily go back to the closet you came out of . This stock is no way in closure proceedings and far from it , for all the chickens who sold today , you will make all the buyers happy in the ensuing days as the English version of the results filter through . What a bargain price Market cap of 15 million at one stage .
Again we were one patient from saying cure , we achieved 88% success rate , Gillead and other have only achieved 85 % and are selling billions a month of their drug and as it turns out is no where near its success rate as was indicated in trials , Biotron has a drug which is not perfect for all is prefect for some , and I would suggest that those patients who are cured will be extremely greatfull for Biotrons endeavours as would their families .
GLTASH , as we may need to wait a little longer .
BIT Price at posting:
6.4¢ Sentiment: Buy Disclosure: Held
